Finding the sweet spot: the role of nature and nurture in medicinal chemistry (original) (raw)

• Madea, B., Mußhoff, F. & Berghaus, G. (eds) Verkehrsmedizin: Fahreignung, Fahrsicherheit, Unfallrekonstruktion 435 (Deutscher Ärzte-Verlag, Köln, 2007).
  Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3–25 (1997).
  CAS Google Scholar
• Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M. & Leeson, P. D. A comparison of physiochemical property profiles of development and marketed oral drugs. J. Med. Chem. 46, 1250–1256 (2003).
  Article CAS PubMed Google Scholar
• Leeson, P. D. & Davis, A. M. Time-related differences in the physical property profiles of oral drugs. J. Med. Chem. 47, 6338–6348 (2004).
  Article CAS PubMed Google Scholar
• Mannhold, R., Poda, G. I., Ostermann, C. & Tetko, I. V. Calculation of molecular lipophilicity: state-of-the-art and comparison of log P methods on more than 96,000 compounds. J. Pharm. Sci. 98, 861–893 (2009).
  Article CAS PubMed Google Scholar
• Oprea, T. I., Davis, A. M., Teague, S. J. & Leeson, P. D. Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci. 41, 1308–1315 (2001).
  Article CAS PubMed Google Scholar
• Hann, M. M., Leach, A. R. & Harper, G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J. Chem. Inf. Comput. Sci. 41, 856–864 (2001).
  Article CAS PubMed Google Scholar
• Hann, M. M. & Oprea, T. I. Pursuing the leadlikeness concept in pharmaceutical research. Curr. Opin. Chem. Biol. 8, 255–263 (2004).
  Article CAS PubMed Google Scholar
• Leeson, P. D. & Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Rev. Drug Discov. 6, 881–890 (2007).
  Article CAS Google Scholar
• Waring, M. Lipophilicity in drug discovery. Expert Opin. Drug Discov. 5, 235–248 (2010).
  Article CAS PubMed Google Scholar
• Waring, M. Defining optimum lipophilicity and molecular weight ranges for drug candidates — molecular weight dependent lower logD limits based on permeability. Bioorg. Med. Chem. Lett. 19, 2844–2851 (2009).
  Article CAS PubMed Google Scholar
• Gleeson, M. P. Generation of a set of simple, interpretable ADMET rules of thumb. J. Med. Chem. 51, 817–834 (2008).
  Article CAS PubMed Google Scholar
• Gleeson, M. P., Hersey, A., Montanari, D. & Overington, J. Probing the links between in vitro potency, ADMET and physicochemical parameters. Nature Rev. Drug Discov. 10, 197–208 (2011).
  Article CAS Google Scholar
• Keserü, G. M. 5th Drug Design Lead Discovery Conference 2009: lead finding strategies and optimization case studies. Drugs Future 35, 143–153 (2010).
  Article Google Scholar
• Hann, M. M. Molecular obesity, potency and other addictions in drug discovery. MedChemComm. 2, 349–355 (2011).
  Article CAS Google Scholar
• Hopkins, A. L., Groom, C. R. & Alex, A. Ligand efficiency: a useful metric for lead selection. Drug Discov. Today 9, 430–431 (2004).
  Article PubMed Google Scholar
• Keserü, G. M. & Makara, G. M. The influence of lead discovery strategies on the properties of drug candidates. Nature Rev. Drug Discov. 8, 203–212 (2009).
  Article Google Scholar
• Ferenczy, G. G. & Keserü, G. M. Thermodynamics guided lead discovery and optimization. Drug Discov. Today 15, 919–932 (2010).
  Article CAS PubMed Google Scholar
• Morphy, R. The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds. J. Med. Chem. 49, 2969–2978 (2006).
  Article CAS PubMed Google Scholar
• Vieth, M. & Sutherland, J. J. Dependence of molecular properties on proteomic family for marketed oral drugs. J. Med. Chem. 49, 3451–3453 (2006).
  Article CAS PubMed Google Scholar
• Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S. & Hopkins, A. L. Global mapping of pharmacological space. Nature Biotech. 24, 805–815 (2006).
  Article CAS Google Scholar
• Southan, C., Boppana, K., Jagarlapudi, S. A. R. P. & Muresan, S. Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: ranking 1654 human protein targets by assayed compounds and molecular scaffolds. J. Cheminform. 3, 14 (2011).
  Article PubMed PubMed Central Google Scholar
• Egner, U. & Hillig, R. C. A structural biology view of target drugability. Expert Opin. Drug Discov. 3, 391–401 (2008).
  Article CAS PubMed Google Scholar
• Edfeldt, F. N. B., Folmer, R. H. A. & Breeze, A. L. Fragment screening to predict druggability (ligandability) and lead discovery success. Drug Discov. Today 16, 284–287 (2011).
  Article CAS PubMed Google Scholar
• Hajduk, P. J., Huth, J. R. & Tse, C. Predicting protein druggability. Drug Discov. Today 10, 1675–1682 (2005).
  Article CAS PubMed Google Scholar
• Swinney, D. C. & Anthony, J. How were new medicines discovered? Nature Rev. Drug Discov. 10, 507–519 (2011).
  Article CAS Google Scholar
• Merelli, X., Bourgeas, R. & Roche, P. Chemical and structural lessons from recent successes in protein–protein interaction inhibition (2P2I). Curr. Opin. Chem. Biol. 15, 1–7 (2011).
  Article Google Scholar
• Alex, A., Millan, D. S., Perez, M., Wakenhut, F. & Whitlock, G. A. Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space. MedChemComm. 2, 669–674 (2011).
  Article CAS Google Scholar
• Leeson, P. D. & St-Gallay, S. A. The influence of the 'organizational factor' on compound quality in drug discovery. Nature Rev. Drug Discov. 10, 749–765 (2011).
  Article CAS Google Scholar
• Tyrchan, C., Blomberg, N., Engkvist, O., Kogej, T. & Muresan, S. Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds. Bioorg. Med. Chem. Lett. 19, 6943–6947 (2009).
  Article CAS PubMed Google Scholar
• Murray, C. W. & Rees, D. C. The rise of fragment-based drug discovery. Nature Chem. 1, 187–192 (2009).
  Article CAS Google Scholar
• Macarron, R. et al. Impact of high-throughput screening in biomedical research. Nature Rev. Drug Discov. 10, 188–195 (2011).
  Article CAS Google Scholar
• Leach, A. R. & Hann, M. M. Molecular complexity and fragment-based drug discovery: ten years on. Curr. Opin. Chem. Biol. 15, 489–496 (2011).
  Article CAS PubMed Google Scholar
• Olsson, T. S., Williams, M. A., Pitt, W. R. & Ladbury, J. E. The thermodynamics of protein–ligand interaction and solvation: insights for ligand design. J. Mol. Biol. 384, 1002–1017 (2008).
  Article CAS PubMed Google Scholar
• Durrant, J. D. & McCammon, J. A. BINANA: a novel algorithm for ligand-binding characterization. J. Mol. Graph. Model. 29, 888–893 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ladbury, J. E., Klebe, G. & Freire, E. Adding calorimetric data to decision making in lead discovery: a hot tip. Nature Rev. Drug Discov. 9, 23–27 (2010).
  Article CAS Google Scholar
• Brandt, T. et al. Congeneric but still distinct: how closely related trypsin ligands exhibit different thermodynamic and structural properties. J. Mol. Biol. 405, 1170–1187 (2011).
  Article CAS PubMed Google Scholar
• Snyder, P. W. et al. Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase. Proc. Natl Acad. Sci. USA 108, 17889–17894 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ferenczy, G. G. & Keserü, G. M. Enthalpic efficiency of ligand binding. J. Chem. Inf. Model. 50, 1536–1541 (2010).
  Article CAS PubMed Google Scholar
• Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there? Nature Rev. Drug Discov. 5, 993–996 (2006).
  Article CAS Google Scholar
• Morphy, R. & Rankovic, Z. Designed multiple ligands. An emerging drug discovery paradigm. J. Med. Chem. 48, 6523–6543 (2005).
  Article CAS PubMed Google Scholar
• Olsson, T. S., Ladbury, J. E., Pitt, W. R. & Williams, M. A. Extent of enthalpy-entropy compensation in protein–ligand interactions. Protein Sci. 20, 1607–1618 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Copeland, R. A., Pompliano, D. L. & Meek, T. D. Drug–target residence time and its implications for lead optimization. Nature Rev. Drug Discov. 5, 730–739 (2006).
  Article CAS Google Scholar
• Schmidtke, P., Luque, F. J., Murray, J. B. & Barril, X. Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design. J. Am. Chem. Soc. 133, 18903–18910 (2011).
  Article CAS PubMed Google Scholar
• Reynolds, C. H., Tounge, B. A. & Bembenek, S. D. Ligand binding efficiency: trends, physical basis, and implications. J. Med. Chem. 51, 2432–2438 (2008).
  Article CAS PubMed Google Scholar
• Reynolds, C. H. & Holloway, M. K. Thermodynamics of ligand binding and efficiency. ACS Med. Chem. Lett. 2, 433–437 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Nissink, J. W. M. Simple size-independent measure of ligand efficiency. J. Chem. Inf. Model. 49, 1617–1622 (2009).
  Article CAS PubMed Google Scholar
• Mortenson, P. N. & Murray, C. W. Assessing the lipophilicity of fragments and early hits. J. Comput. Aided Mol. Des. 25, 663–667 (2011).
  Article CAS PubMed Google Scholar
• Wager, T. T. et al. Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. ACS Chem. Neurosci. 1, 420–434 (2010).
  CAS PubMed PubMed Central Google Scholar
• Tarcsay, A., Nyiri, K. & Keserü, G. M. The impact of lipophilic efficiency on compound quality. J. Med. Chem. 55, 1252–1260 (2012).
  Article CAS PubMed Google Scholar
• Wager, T. T., Hou, X., Verhoest, P. R. & Villalobos, A. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chem. Neurosci. 1, 435–449 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Dack, K. Reducing Attrition Risk: Evolution of an in silico 'Compound Safety Evaluator'. Designing Safer Medicines In Discovery Symposium (Society of Chemical Industry, London, 17 March 2011).
  Google Scholar
• Braggio, S., Montanari, D., Rossi, T. & Ratti, E. Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates. Expert Opin. Drug Discov. 5, 609–618 (2010).
  Article CAS PubMed Google Scholar
• Montanari, D. et al. Application of drug efficiency index in drug discovery: a strategy towards low therapeutic dose. Expert Opin. Drug Discov. 6, 913–920 (2011).
  Article CAS PubMed Google Scholar
• Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S. & Hopkins, A. L. Quantifying druglikeness and target druggability. Nature Chem. 4, 90–98 (2012).
  Article CAS Google Scholar
• Stepan, A. F. et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem. Res. Toxicol. 24, 1345–1410 (2011).
  Article CAS PubMed Google Scholar
• Cooper, T. W., Campbell, I. B. & Macdonald, S. J. Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). Angew. Chem. Int. Ed. Engl. 49, 8082–8091 (2010).
  Article CAS PubMed Google Scholar
• Roughley, S. D. & Jordan, A. M. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. J. Med. Chem. 54, 3451–3479 (2011).
  Article CAS PubMed Google Scholar
• Walters, W. P., Green, J., Weiss, J. R. & Murcko, M. A. What do medicinal chemists actually make? A 50-year retrospective. J. Med. Chem. 54, 6405–6416 (2011).
  Article CAS PubMed Google Scholar
• Pitt, W. R., Parry, D. M., Perry, B. G. & Groom, C. R. Heteroaromatic rings of the future. J. Med. Chem. 52, 2952–2963 (2009).
  Article CAS PubMed Google Scholar
• Darvas, F. et al. High pressure, high temperature reactions in continuous flow. Merging discovery and process chemistry. Chemistry Today 27, 40–43 (2009).
  CAS Google Scholar
• Wegner, J., Ceylan, S. & Kirschning, A. Ten key issues in modern flow chemistry. Chem. Commun. (Camb.) 47, 4583–4592 (2011).
  Article CAS Google Scholar
• Nadin, A., Hattotuwagama, C. & Churcher, I. Lead-oriented synthesis: a new opportunity for synthetic chemistry. Angew. Chem. Int. Ed. Engl. 51, 1114–1122 (2011).
  Article Google Scholar
• Tan, D. S. Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nature Chem. Biol. 1, 74–84 (2005).
  Article CAS Google Scholar
• Jones, S. B., Simmons, B., Mastracchio, A. & MacMillan, D. W. C. Collective synthesis of natural products by means of organocascade catalysis. Nature 475, 183–188 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hill, A. P. & Young, R. J. Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity. Drug Discov. Today 15, 648–655 (2010).
  Article CAS PubMed Google Scholar
• Young, R. J., Green, D. V., Luscombe, C. N. & Hill, A. P. Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity. Drug Discov. Today 16, 822–830 (2011).
  Article CAS PubMed Google Scholar
• Hughes, J. D. et al. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg. Med. Chem. Lett. 18, 4872–4875 (2008).
  Article CAS PubMed Google Scholar
• Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Rev. Drug Discov. 9, 203–214 (2010).
  Article CAS Google Scholar
• Dimitri, N. An assessment of R&D productivity in the pharmaceutical industry. Trends Pharm. Sci. 32, 683–685 (2011).
  Article CAS PubMed Google Scholar
• Butler, J. M. & Dressman, J. B. The developability classification system: application of biopharmaceutics concepts to formulation development. J. Pharm. Sci. 99, 4940–4954 (2010).
  Article CAS PubMed Google Scholar
• Bennani, Y. Drug discovery in the next decade: innovation needed ASAP. Drug Discov. Today 16, 779–792 (2011).
  Article PubMed Google Scholar
• Abad-Zapatero, C. & Metz, J. T. Ligand efficiency indices as guideposts for drug discovery. Drug Discov. Today 10, 464–469 (2005).
  Article PubMed Google Scholar
• Orita, M., Ohno, K. & Niimi, T. Two 'golden ratio' indices in fragment-based drug discovery. Drug Discov. Today 14, 321–328 (2009).
  Article CAS PubMed Google Scholar